← Компания

ID_KLBF 2024-09-30 9M — report review

Status: OK; Currency: IDR; Amounts unit: millions; Forms: ✓ ✓ ✓

Дата публикации отчёта: Не сохранена для этого периода — укажите financial_report_date в строке (EDGAR filingDate, KASE change_date или manual_catalog).

Full financial report: Отчёт (PDF)

PDF (local): data/raw_pdfs/ID_KLBF/2024-09-30_9M_KLBF_Q3_2024.pdf

Чтобы заново выполнить поиск форм и превью из PDF, откройте эту ссылку Основная ссылка запускает пересчёт в фоне: панель статуса, затем готовая страница. Тяжёлый режим с refresh по умолчанию тоже в фоне (иначе прокси даёт 502). &sync=1 — только для одного долгого синхронного ответа (не рекомендуется). Можно ?refresh=1, ?recalc=1, ?nocache=1 или ?recompute=1. (дождаться в браузере: синхронное обновление)

Сопоставление метрик (значение → evidence)

Значения метрик приведены к единицам дашборда, где это применимо; в колонке evidence — сохранённый фрагмент из текстового слоя PDF или OCR на этапе извлечения.

Statement pages (discovery)

Превью страниц и восстановленные таблицы

Подсветка Жёлтая строка — совпадение с evidence; оранжевая ячейка — точное число, взятое для метрики (наведите на строку). Выручка Опер. прибыль Аморт. и износ EBITDA Чистая прибыль cash debt_short debt_long Активы Капитал Операц. ДДС Инвест. ДДС

Зелёная / янтарная / красная полоса у подписи строки — итог/субитог, где сумма детальных строк сравнивается с числом в отчёте (эвристика). Под каждой таблицей — список проверок (Σ строк vs отчёт, статус).

P&L

P&L — PDF page 5

No Camelot table — OCR (v8) below.

GPU v8 OCR — page 5 (34 rows). Blank amount cells are normal for section headers and line-wrapped captions; 0 from OCR on those rows is not a reported financial zero. Amounts follow the PDF header (often thousands of currency).

#	Joined label	Column 2	Column 3	Column 4
0	The original consolidated financial statements included herein are in
1	the Indonesian language:
2	PT KALBE FARMA Tbk DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk AND ITS SUBSIDIARIES
3	LAPORAN POSISI KEUANGAN KONSOLIDASIAN CONSOLIDATED STATEMENT
4	Tanggal 30 September 2024 (Belum Diaudit) OF FINANCIAL POSITION
5	(Disajikan dalam Rupiah, kecuali dinyatakan lain) As of September 30, 2024 (Unaudited)
6	(Expressed in Rupiah, unless otherwise stated)
7	ASET
8	ASET LANCAR
9	Kas dan setara kas	4174378727489	2.4	3232420596769
10	Piutang usaha	0	2.3
11	Pihak ketiga, neto	4955221844516	0	4600108623230
12	Pihak berelasi	45658479093	8	51862073259
13	Piutang lain-lain	0	2.6
14	Pihak ketiga	179611447346	0	155021066866
15	Pihak berelasi	9658669828	8000000000	13149147203
16	Aset keuangan lancar lainnya	141997010523	2.7	165496270442
17	Persediaan neto	6506232530170	2.3	6791979793011
18	Pajak pertambahan nilai
19	dibayar di muka	644590691677	2.3	465509623490
20	Biaya dibayar di muka	57810279978	10	37371816832
21	Aset lancar lainnya	317473093700	11	404805089758
22	Total Aset Lancar	17032632774320	0	15917724100860
23	ASET TIDAK LANCAR
24	Aset keuangan tidak lancar lainnya	305208429093	2.12	321056181886
25	Investasi pada entitas asosiasi	150572820695	2.3	129742418236
26	Aset pajak tangguhan; neto	132625800949	2.3	136102644092
27	Tagihan restitusi pajak	121698363800	2.3	128669562280
28	Aset tetap neto	8162895208463	2.3	7978027474025
29	Aset takberwujud, neto	2201274296789	2.3	1778032069582
30	Aset hak-guna, neto	86168900511	2.3	89013773105
31	Aset tidak lancar lainnya	558705893784	2.3	579199958257
32	Total Aset Tidak Lancar	11719149714084	0	11139844081463
33	TOTAL ASET	28751782488404	0	27057568182323

P&L — PDF page 6

No Camelot table — OCR (v8) below.

GPU v8 OCR — page 6 (40 rows). Blank amount cells are normal for section headers and line-wrapped captions; 0 from OCR on those rows is not a reported financial zero. Amounts follow the PDF header (often thousands of currency).

#	Joined label	Column 2	Column 3	Column 4
0	The original consolidated financial statements included herein are in
1	the Indonesian language:
2	PT KALBE FARMA Tbk DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk AND ITS SUBSIDIARIES
3	LAPORAN POSISI KEUANGAN KONSOLIDASIAN CONSOLIDATED STATEMENT
4	(lanjutan) OF FINANCIAL POSITION (continued)
5	Tanggal 30 September 2024 (Belum Diaudit) As of September 30, 2024 (Unaudited)
6	(Disajikan dalam Rupiah; kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)
7	LIABILITAS
8	LIABILITAS JANGKA PENDEK
9	Utang bank jangka pendek	318600000000	2.18	120800000000
10	Utang usaha	0	2.2
11	Pihak ketiga	1803054001544	0	1584837372868
12	Pihak berelasi	143479073280	8	105882232758
13	Utang lain-lain	0	2.21
14	Pihak ketiga	728205448371	0	547972415828
15	Pihak berelasi	1129617833	8	255875577
16	Beban akrual	666604399714	2.22	369115840662
17	Liabilitas imbalan kerja
18	jangka pendek	116055658288	2	109425250214
19	Utang pajak	240845830899	2.3	225196597099
20	Bagian jangka pendek dari:
21	Utang bank	74898108467	2.18	157493959061
22	Liabilitas sewa	11176849449	2.3	21465468538
23	Utang pembiayaan	723532320	2	723532320
24	Total Liabilitas Jangka Pendek	4104772520165	0	3243168544925
25	LIABILITAS JANGKA PANJANG
26	Pinjaman jangka panjang,
27	setelah dikurangi dengan
28	bagian jangka pendek:
29	Utang bank	198292003690	2.18	298336872439
30	Liabilitas sewa	16887646247	2.3	20442051140
31	Utang pembiayaan	1769121193	2	2365264318
32	Utang obligasi	121104000000	2.19
33	Liabilitas pajak tangguhan, neto	38567746886	2.3	35789992933
34	Liabilitas imbalan kerja
35	jangka panjang	358146304048	2.3	336943622353
36	Utang lain-lain jangka panjang
37	Pihak berelasi	499824000	2.8	499824000
38	Total Liabilitas Jangka Panjang	735266646064	0	694377627183
39	TOTAL LIABILITAS	4840039166229	0	3937546172108

BS

BS — PDF page 7

Camelot table (pages 7, primary page 7).

#	Joined label	Line item	Column 2	Column 3	Equity Attributable to → Owners o…
0	Diatribusikan kepada Equity Attributable to	Diatribusikan kepada			Equity Attributable to
1	Pemilik Entitas Induk Owners of the Parent Company	Pemilik Entitas Induk			Owners of the Parent Company
2	Modal saham - nilai nominal Share capital - Rp10 par value	Modal saham - nilai nominal			Share capital - Rp10 par value
3	Rp10 per saham per share	Rp10 per saham			per share
4	Modal dasar - Authorized -	Modal dasar -			Authorized -
5	85.000.000.000 saham 85,000,000,000 shares	85.000.000.000 saham			85,000,000,000 shares
6	Modal ditempatkan dan disetor Issued and fully paid -	Modal ditempatkan dan disetor			Issued and fully paid -
7	penuh - 46.875.122.110 saham 468.751.221.100 24 46,875,122,110 shares 468.751.221.100	penuh - 46.875.122.110 saham	468.751.221.100	24	46,875,122,110 shares 468.751.221.100
8	Tambahan modal disetor, neto (33.093.373.814) 2,25 (34.118.673.814) Additional paid-in capital, net	Tambahan modal disetor, neto	(33.093.373.814)	2,25	(34.118.673.814) Additional paid-in capital, net
9	Selisih transaksi dengan Differences arising from transaction	Selisih transaksi dengan			Differences arising from transaction
10	kepentingan non-pengendali 377.187.510.852 2,26 377.208.986.365 with non-controlling interests	kepentingan non-pengendali	377.187.510.852	2,26	377.208.986.365 with non-controlling interests
11	Saldo laba Retained earnings	Saldo laba			Retained earnings
12	Telah ditentukan penggunaannya 371.687.456.205 24 344.019.975.805 Appropriated	Telah ditentukan penggunaannya	371.687.456.205	24	344.019.975.805 Appropriated
13	Belum ditentukan penggunaannya 22.079.533.763.494 24 21.162.752.455.815 Unappropriated	Belum ditentukan penggunaannya	22.079.533.763.494	24 21.162.752.455.815	Unappropriated
14	Saham treasuri - Treasury stock -	Saham treasuri -			Treasury stock -
15	725.940.900 saham pada 725,940,900 shares as of	725.940.900 saham pada			725,940,900 shares as of
16	30 September 2024 dan September 30, 2024 and	30 September 2024 dan			September 30, 2024 and
17	619.480.700 saham pada 619,480,700 shares as of	619.480.700 saham pada			619,480,700 shares as of
18	31 Desember 2023 (1.169.673.482.500) 2,24 (1.003.973.113.000) December 31, 2023	31 Desember 2023	(1.169.673.482.500)	2,24 (1.003.973.113.000)	December 31, 2023
19	Penghasilan komprehensif lain Other comprehensive income	Penghasilan komprehensif lain			Other comprehensive income
20	Selisih kurs atas penjabaran Differences arising from foreign	Selisih kurs atas penjabaran			Differences arising from foreign
21	laporan keuangan 31.593.993.368 2 currency translation 40.083.774.764	laporan keuangan	31.593.993.368	2	currency translation 40.083.774.764
22	Laba belum direalisasi Unrealized gain on	Laba belum direalisasi			Unrealized gain on
23	dari aset keuangan tersedia available-for-sale	dari aset keuangan tersedia			available-for-sale

No subtotal/total rows matched the built-in patterns on this table (or fewer than two detail lines above each candidate).

BS — PDF page 8

Camelot table (pages 8, primary page 8).

#	Joined label	Line item	2024	NET SALES → COST OF GOODS SOLD
0	Period Ended September 30		Period Ended September 30
1	Catatan/		Catatan/
2	2024 Notes 2023*)		2024 Notes 2023*)
3	PENJUALAN NETO 24.238.762.731.250 2,8,28,29 22.561.006.413.774 NET SALES	PENJUALAN NETO	24.238.762.731.250 2,8,28,29 22.561.006.413.774	NET SALES
4	BEBAN POKOK PENJUALAN (14.721.787.709.511) 2,8,28,30 (13.658.036.825.593) COST OF GOODS SOLD	BEBAN POKOK PENJUALAN	(14.721.787.709.511) 2,8,28,30 (13.658.036.825.593)	COST OF GOODS SOLD
5	LABA BRUTO 9.516.975.021.739 8.902.969.588.181 GROSS PROFIT	LABA BRUTO	9.516.975.021.739 8.902.969.588.181	GROSS PROFIT
6	Beban penjualan (5.048.821.010.429) 2,28,31 (4.780.180.934.888) Selling expenses	Beban penjualan	(5.048.821.010.429) 2,28,31 (4.780.180.934.888)	Selling expenses
7	General and administrative			General and administrative
8	Beban umum dan administrasi (1.148.357.738.062) 2,28,32 (1.136.891.384.647) expenses	Beban umum dan administrasi	(1.148.357.738.062) 2,28,32 (1.136.891.384.647)	expenses
9	Beban penelitian Research and development	Beban penelitian		Research and development
10	dan pengembangan (317.511.602.092) 2,28,33 (271.166.193.511) expenses	dan pengembangan	(317.511.602.092) 2,28,33 (271.166.193.511)	expenses
11	Pendapatan operasi lainnya 39.981.363.106 2,8,28,37 45.509.616.187 Other operating income	Pendapatan operasi lainnya	39.981.363.106 2,8,28,37 45.509.616.187	Other operating income
12	Beban operasi lainnya (51.696.471.265) 2,28,36 (125.517.991.864) Other operating expenses	Beban operasi lainnya	(51.696.471.265) 2,28,36 (125.517.991.864)	Other operating expenses
13	Penghasilan bunga 129.401.556.122 2,28,35 63.218.722.644 Interest income	Penghasilan bunga	129.401.556.122 2,28,35 63.218.722.644	Interest income
14	Interest expense and			Interest expense and
15	Beban bunga dan keuangan (50.481.708.146) 2,28,34 (76.569.802.324) financial charges	Beban bunga dan keuangan	(50.481.708.146) 2,28,34 (76.569.802.324)	financial charges
16	Bagian atas laba Share in gain of the	Bagian atas laba		Share in gain of the
17	entitas asosiasi, neto 22.550.294.857 2,13,23,28 29.709.586.584 associates, net	entitas asosiasi, neto	22.550.294.857 2,13,23,28 29.709.586.584	associates, net
18	LABA SEBELUM BEBAN INCOME BEFORE	LABA SEBELUM BEBAN		INCOME BEFORE
19	PAJAK PENGHASILAN 3.092.039.705.830 2.651.081.206.362 INCOME TAX EXPENSE	PAJAK PENGHASILAN	3.092.039.705.830 2.651.081.206.362	INCOME TAX EXPENSE
20	BEBAN PAJAK PENGHASILAN (695.705.504.166) 2,3,23,28 (577.784.847.033) INCOME TAX EXPENSE	BEBAN PAJAK PENGHASILAN	(695.705.504.166) 2,3,23,28 (577.784.847.033)	INCOME TAX EXPENSE
21	LABA PERIODE BERJALAN 2.396.334.201.664 2.073.296.359.329 INCOME FOR THE PERIOD	LABA PERIODE BERJALAN	2.396.334.201.664 2.073.296.359.329	INCOME FOR THE PERIOD
22	PENGHASILAN OTHER COMPREHENSIVE	PENGHASILAN		OTHER COMPREHENSIVE
23	KOMPREHENSIF LAIN INCOME	KOMPREHENSIF LAIN		INCOME
24	Pos yang tidak akan Item that will not be	Pos yang tidak akan		Item that will not be
25	direklasifikasi ke laba rugi - - reclassified to profit or loss	direklasifikasi ke laba rugi	- -	reclassified to profit or loss
26	Pos-pos yang akan direklasifikasi Items that will be reclassified	Pos-pos yang akan direklasifikasi		Items that will be reclassified
27	ke laba rugi: to profit or loss:	ke laba rugi:		to profit or loss:

No subtotal/total rows matched the built-in patterns on this table (or fewer than two detail lines above each candidate).

CF

CF — PDF page 9

No Camelot table — OCR (v8) below.

GPU v8 OCR — page 9 (23 rows). Blank amount cells are normal for section headers and line-wrapped captions; 0 from OCR on those rows is not a reported financial zero. Amounts follow the PDF header (often thousands of currency).

#	Joined label	Column 2	Column 3	Column 4
0	The original consolidated financial statements included herein are in
1	the Indonesian language:
2	PT KALBE FARMA Tbk: DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk AND ITS SUBSIDIARIES
3	LAPORAN LABA RUGI DAN PENGHASILAN CONSOLIDATED STATEMENT OF PROFIT OR LOSS
4	KOMPREHENSIF LAIN KONSOLIDASIAN AND OTHER COMPREHENSIVE INCOME
5	(lanjutan) (continued)
6	Untuk Periode yang berakhir pada Tanggal For the Period Ended September 30, 2024
7	30 September 2024 (Belum Diaudit) (Unaudited)
8	(Disajikan dalam Rupiah; kecuali dinyatakan lain) (Expressed in Rupiah; unless otherwise stated)
9	Laba Periode Berjalan Yang
10	Dapat Diatribusikan Kepada:
11	Pemilik entitas induk	2378379096789	2.28	2064925608770
12	Kepentingan non-pengendali	17955104875	2.28	8370750559
13	Total	2396334201664	0	2073296359329
14	Total Laba Komprehensif
15	Periode Berjalan Yang Dapat
16	Diatribusikan Kepada:
17	Pemilik entitas induk	2363031356266	0	2048051126353
18	Kepentingan non-pengendali	17955104875	2.28	8370750677
19	Total	2380986461141	0	2056421877030
20	Laba per Saham Dasar
21	Yang Dapat Diatribusikan
22	kepada Pemilik Entitas Induk	51.34	2.24	44.39

Formulas used

• Net debt: debt_short + debt_long + other_financial_liabilities + non_controlling_interest − cash (mln); [DeepSeek] net_debt (mln IDR, batch apply)
• EBITDA: operating_profit + da (mln)